$13.04
0.120.93%
At close: -
$13.11
0.070.54%
After Hours: Mar 21, 7:54 PM EDT
Comments
Loading...
Oscar Health Analyst Ratings and Price Targets | NYSE:OSCR | Benzinga
Oscar Health Inc has a consensus price target of $16.79 based on the ratings of 12 analysts. The high is $28 issued by Piper Sandler on September 10, 2024. The low is $6 issued by Cowen & Co. on February 14, 2023. The 3 most-recent analyst ratings were released by Wells Fargo, Jefferies, and B of A Securities on March 13, 2025, December 10, 2024, and November 6, 2024, respectively. With an average price target of $13.83 between Wells Fargo, Jefferies, and B of A Securities, there's an implied 5.52% upside for Oscar Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Jefferies
B of A Securities
UBS
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Oscar Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | Buy Now | 22.04% | Wells Fargo | Stephen Baxter54% | $20 → $16 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/10/2024 | Buy Now | -8.47% | Jefferies | David Windley74% | → $12 | Initiates | → Underperform | Get Alert |
| 11/06/2024 | Buy Now | 2.97% | B of A Securities | Adam Ron61% | $21 → $13.5 | Downgrade | Neutral → Underperform | Get Alert |
| 10/07/2024 | Buy Now | 75.44% | UBS | Jonathan Yong64% | → $23 | Initiates | → Neutral | Get Alert |
| 09/10/2024 | Buy Now | 113.58% | Piper Sandler | Jessica Tassan40% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2024 | Buy Now | 113.58% | Piper Sandler | Jessica Tassan40% | $25 → $28 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | 90.69% | Piper Sandler | Jessica Tassan40% | $25 → $25 | Maintains | Overweight | Get Alert |
| 06/26/2024 | Buy Now | 90.69% | Piper Sandler | Jessica Tassan40% | → $25 | Initiates | → Overweight | Get Alert |
| 06/12/2024 | Buy Now | 105.95% | Wells Fargo | Stephen Baxter54% | $24 → $27 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 60.18% | B of A Securities | Adam Ron61% | $25 → $21 | Downgrade | Buy → Neutral | Get Alert |
| 05/30/2024 | Buy Now | 113.58% | Baird | Michael Ha48% | → $28 | Initiates | → Outperform | Get Alert |
| 05/20/2024 | Buy Now | 90.69% | B of A Securities | Adam Ron61% | $22 → $25 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 83.07% | Wells Fargo | Stephen Baxter54% | $20 → $24 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | 60.18% | Goldman Sachs | Nathan Rich43% | $16 → $21 | Maintains | Neutral | Get Alert |
| 03/22/2024 | Buy Now | 52.56% | Raymond James | John Ransom76% | → $20 | Initiates | → Outperform | Get Alert |
| 02/15/2024 | Buy Now | 52.56% | Wells Fargo | Stephen Baxter54% | $12 → $20 | Maintains | Overweight | Get Alert |
| 02/09/2024 | Buy Now | 22.04% | Goldman Sachs | Nathan Rich43% | $8 → $16 | Maintains | Neutral | Get Alert |
| 02/08/2024 | Buy Now | 52.56% | B of A Securities | Adam Ron61% | $10 → $20 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | -23.72% | B of A Securities | Adam Ron61% | $9 → $10 | Maintains | Buy | Get Alert |
| 11/02/2023 | Buy Now | -31.35% | B of A Securities | Adam Ron61% | $8 → $9 | Upgrade | Neutral → Buy | Get Alert |
| 08/30/2023 | Buy Now | -42.79% | Morgan Stanley | Ricky Goldwasser78% | $5 → $7.5 | Maintains | Equal-Weight | Get Alert |
| 08/10/2023 | Buy Now | -42.79% | Goldman Sachs | Nathan Rich43% | $5.5 → $7.5 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | -35.16% | Credit Suisse | Jonathan Yong64% | $7 → $8.5 | Maintains | Outperform | Get Alert |
| 07/14/2023 | Buy Now | -61.86% | Morgan Stanley | Ricky Goldwasser78% | $5 → $5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/13/2023 | Buy Now | -8.47% | Wells Fargo | Stephen Baxter54% | $8.5 → $12 | Maintains | Overweight | Get Alert |
| 06/06/2023 | Buy Now | -33.26% | B of A Securities | Adam Ron61% | $5.4 → $8.75 | Upgrade | Underperform → Neutral | Get Alert |
| 05/17/2023 | Buy Now | -35.16% | Wells Fargo | Stephen Baxter54% | $6.75 → $8.5 | Maintains | Overweight | Get Alert |
| 05/10/2023 | Buy Now | -46.61% | Credit Suisse | Jonathan Yong64% | $6 → $7 | Maintains | Outperform | Get Alert |
| 03/29/2023 | Buy Now | -70.25% | B of A Securities | Adam Ron61% | $3.25 → $3.9 | Maintains | Underperform | Get Alert |
| 02/14/2023 | Buy Now | -54.23% | Cowen & Co. | Gary Taylor59% | $3 → $6 | Maintains | Market Perform | Get Alert |
| 02/14/2023 | Buy Now | -61.86% | Goldman Sachs | Nathan Rich43% | $3.5 → $5 | Maintains | Neutral | Get Alert |
| 02/10/2023 | Buy Now | -54.23% | Credit Suisse | Jonathan Yong64% | $7 → $6 | Maintains | Outperform | Get Alert |
| 11/16/2022 | Buy Now | -69.49% | Wells Fargo | Stephen Baxter54% | → $4 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/14/2022 | Buy Now | -61.86% | Morgan Stanley | Ricky Goldwasser78% | $9 → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/01/2022 | Buy Now | -31.35% | Morgan Stanley | Ricky Goldwasser78% | $12 → $9 | Maintains | Overweight | Get Alert |
| 06/15/2022 | Buy Now | -65.68% | B of A Securities | Adam Ron61% | $6 → $4.5 | Downgrade | Neutral → Underperform | Get Alert |
| 06/09/2022 | Buy Now | -8.47% | Morgan Stanley | Ricky Goldwasser78% | $18 → $12 | Maintains | Overweight | Get Alert |
| 05/26/2022 | Buy Now | -54.23% | B of A Securities | Adam Ron61% | $12 → $6 | Downgrade | Buy → Neutral | Get Alert |
| 03/28/2022 | Buy Now | 37.3% | Morgan Stanley | Craig Hettenbach59% | $20 → $18 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Oscar Health (OSCR) stock?
The latest price target for Oscar Health (NYSE:OSCR) was reported by Wells Fargo on March 13, 2025. The analyst firm set a price target for $16.00 expecting OSCR to rise to within 12 months (a possible 22.04% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Oscar Health (OSCR)?
The latest analyst rating for Oscar Health (NYSE:OSCR) was provided by Wells Fargo, and Oscar Health downgraded their equal-weight rating.
When was the last upgrade for Oscar Health (OSCR)?
The last upgrade for Oscar Health Inc happened on November 2, 2023 when B of A Securities raised their price target to $9. B of A Securities previously had a neutral for Oscar Health Inc.
When was the last downgrade for Oscar Health (OSCR)?
The last downgrade for Oscar Health Inc happened on March 13, 2025 when Wells Fargo changed their price target from $20 to $16 for Oscar Health Inc.
When is the next analyst rating going to be posted or updated for Oscar Health (OSCR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Oscar Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Oscar Health was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
Is the Analyst Rating Oscar Health (OSCR) correct?
While ratings are subjective and will change, the latest Oscar Health (OSCR) rating was a downgraded with a price target of $20.00 to $16.00. The current price Oscar Health (OSCR) is trading at is $13.11, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.